Development and Validation of a Self-administered QUestionnaire to Identify Levers of Adhesion Behavior to Patient's Medication in Order to Adapt the Educational Monitoring.
- Conditions
- Patient Education as TopicSurveys and QuestionnairesMedication AdherencePulmonary Disease, Chronic ObstructiveDiabetes Mellitus, Type 2Heart Failure
- Registration Number
- NCT02865525
- Lead Sponsor
- University Hospital, Grenoble
- Brief Summary
Medication non-adherence is an economic problem and a major public health challenge. Factors influencing medication adherence can be modelled according to five dimensions: disease, medication, patient and its close relatives, demographic and socioeconomic factors and health care system. A tool is needed to qualify medication adherence in order to adapt tailored support for individual patients to promote and optimize adherence to therapy.
The objective of this work is to present the preliminary results of QUILAM project which is divided into 3 phases: 1. Development of a tool to assess barriers to medication adherence in chronic patient (COPD, Heart failure, Type 2 diabetes) ; 2. Validation of the instrument (especially against clinical criteria) ; 3. Evaluation of the sensitivity of the tool during educational interventions.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 282
- Patient with at least one of the following pathologies: diabetes type II, COPD, heart failure
- person available for a follow-up of 1 year
- Affiliated to the social security or recipient of such a regime
- Persons referred to in articles L1121-5 and L1121-8 in the french public health code
- Patient who do not speak french
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of events 'hospitalization and death' for 2 patient groups defined through the questionnaire QUILAM score 12 month
- Secondary Outcome Measures
Name Time Method Reliability over time of the questionnaire (test-retest J0 - J15) 12 month Number of clinical events for 2 patient groups 12 month Feasibility and acceptability of the questionnaire (duration / missing data) 12 month External construct validity (Girerd, SatMedQ, BMQ) 12 month Number of events 'hospitalization and death' for 2 patient groups separate with different cut off 12 month
Trial Locations
- Locations (1)
Grenoble University Hospital
🇫🇷Grenoble cedex 9, France
Grenoble University Hospital🇫🇷Grenoble cedex 9, France